evaluate the pharmaceuticals and biotechnology company novo nordisk on glp-1's testing its blockbuster GLP-1 drugs in Alzheimer's GLP-1 | Summary

A) all generic cos were very low on their GLP1 forecast before the launch - a few 10s of crores at best in the 1st year eg A top co in India had a 10cr first yr sales forecast and is set to do a multiplier of that On top of that fewer than expected cos have launched B) online sales which is the biggest area of growth on GLP1s (pharmacies / Telehealth) doesnt get captured and so is direct sales

Pueden la creatina o la L-carnitina reivindicar el tratamiento de enfermedades

These markings are similar to those used in a Mallard-type rotation advancement

Because of these risks, many dermatologists and medical bodies strongly discourage the use of injectable glutathione for cosmetic/lightening purposes

Evidence suggests that l-carnitine improves anemia and inflammation in people with this condition